Skip to main content
. 2021 Nov 19;50(3):651–659. doi: 10.1007/s15010-021-01728-0

Table 3.

Sensitivity, specificity, positive and negative predictive values for mortality and disease progression for all scores and their original cut-offs

Score Cut-off n (%) Sensitivity [95%-CI] Specificity [95%-CI] PPV [95%-CI] NPV [95%-CI]
Mortality
CALL ≥ 6 points 284 (96%) 100% [94.2–100] 5.5% [3.0–9.3] 21.8% [17.2–27.1] 100% [75.3–100]
≥ 9 points 219 (74%) 93.5% [84.3–98.2] 31.5% [25.6–37.8] 26.5% [20.8–32.9] 94.9% [87.4–98.6]
CHOSEN ≤ 30 points 135 (36%) 62.3% [50.6–73.1] 71.3% [65.8–76.3] 35.6% [27.5–44.2] 88.2% [83.4–91.9]
HA2T2 ≥ 3 points 29 (19%) 39.5% [25.0–55.6] 88.9% [81.4–94.1] 58.6% [38.9–76.5] 78.7% [70.4–85.6]
ANDC < 59 points 11 (9%) 0.0% [0.0–10.6] 87.9% [79.4–93.8] 0.0% [0.0–28.5] 70.8% [61.5–79.0]
59–101 points 79 (64%) 57.6% [39.2–74.5] 34.1% [24.5–44.7] 24.1% [15.1–35.0] 68.9% [53.4–81.8]
> 101 points 34 (27%) 42.4% [25.5–60.8] 78.0% [68.1–86.0] 41.2% [24.6–59.3] 78.9% [69.0–86.8]
Disease progressiona
CALL ≥ 6 points 284 (96%) 98.0% [93.0–99.8] 5.6% [2.8–9.8] 34.9% [29.3–40.7] 84.6% [54.6–98.1]
≥ 9 points 219 (74%) 84.2% [75.6–90.7] 31.6% [25.2–38.6] 38.8% [32.3–45.6] 79.5% [68.8–87.8]
CHOSEN ≤ 30 points 135 (36%) 53.3% [44.0–62.5] 72.7% [66.8–78] 47.4% [38.8–56.2] 77.1% [71.4–82.2]
HA2T2 ≥ 3 points 29 (19%) 23.8% [15.2–34.3] 86.6% [76.0–93.7] 69.0% [49.2–84.7] 47.5% [38.4–56.8]
ANDC < 59 points 11 (9%) 4.9% [1.0–13.7] 87.3% [76.5–94.4] 27.3% [6.0–61.0] 48.7% [39.2–58.3]
59–101 points 79 (64%) 60.7% [47.3–72.9] 33.3% [22–46.3] 46.8% [35.5–58.4] 46.7% [31.7–62.1]
> 101 points 34 (27%) 34.4% [22.7–47.7] 79.4% [67.3–88.5] 61.8% [43.6–77.8] 55.6% [44.7–66.0]

CI confidence interval, NPV negative predictive value, PPV positive predictive value

aDefined as invasive ventilation, ICU admission or death